TABLE 4.
Characteristics | No. Patients | Overall Survival | |
---|---|---|---|
HR (95% CI) | P | ||
pT stage (AJCC 8th edition) | 0.47 | ||
pT1 (reference) | 12 | 1.00 | |
pT2 | 61 | 1.75 (0.64–4.82) | 0.28 |
pT3 | 11 | 1.32 (0.38–4.56) | 0.66 |
pN stage (AJCC 8th edition) | 0.01 | ||
pN0 (reference) | 16 | 1.00 | |
pN1 | 32 | 2.46 (0.92–6.62) | 0.07 |
pN2 | 36 | 4.25 (1.56–11.59) | 0.005 |
Margin | |||
Negative (reference) | 75 | 1.00 | |
Positive | 9 | 3.96 (1.66–9.47) | 0.002 |
PERK expression | |||
Low (reference) | 42 | 1.00 | |
High | 42 | 1.00 (0.51–1.94) | 0.99 |
p-eIF2α Expression | |||
Low (reference) | 37 | 1.00 | |
High | 47 | 2.13 (1.17–3.89) | 0.01 |